Lori Freedman bought $699K of Organogenesis (ORGO)

Executed Jun 4 2025, disclosed Jun 6 2025, 2 days later.

Value, as filed

$699K

243,242 sh across 2 lots

Executed

Jun 4 2025

the trade date, as filed

Disclosed

Jun 6 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+56.4%

+51.8% from execution

Over the 21 trading sessions from the disclosed entry session (Jun 6 2025), the stock returned +56.4% (delay-adjusted); from the execution session (Jun 4 2025), +51.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

LF Lori Freedman Chief Admin. and Legal Officer profile →

Lori Freedman (Chief Admin. and Legal Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in ORGO. Across 1 priced purchase filing, the average 21-session return was +51.8% from execution and +56.4% from disclosure (delay-adjusted; derived). The largest single filing was $699K of ORGO (243,242 sh across 2 lots, as filed), executed Jun 4 2025.

The name

ORGO ORGO ORGO · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→